Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetes

Acta Diabetologica

Volumn 49, Issue 1 SUPPL., 2012, Pages

  Blank, Sally E ^a   Johnson, Emily Carolyn ^a   Weeks, Debra K ^a   Wysham, Carol H ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Rockwood Clinic   (United States)

Author keywords

Glycemic control; Myeloid dendritic cells; Plasmacytoid dendritic cells; Tumor necrosis factor alpha

Indexed keywords

CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD33 ANTIGEN; CD85K ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PLASMACYTOID DENDRITIC CELL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; CASE CONTROL STUDY; CELL COUNT; CONTROLLED CLINICAL TRIAL; CYTOLOGY; IMMUNOLOGY; MENOPAUSE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL COUNT; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878894984     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0190-8     Document Type: Article

References (52)

1. Guest C, Park M, Johnson D, Freund G (2008) The implication of proinflammatory cytokines in type 2 diabetes. Front Biosci 13:5187-5194
2. Pickup J (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813-823
3. Pickup J, Chusney G, Thomas S, Burt D (2000) Plasma interleukin-6, tumor necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300
4. Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K (1998) Elevated serum tumor necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 41:860-862
5. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862
6. Bastard J-P, Maachi M, Lagathu C, Kim M, Vidal V, Caron M, Capeau J, Feve B (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12
7. Plomgaard P, Nielsen A, Fischer C, Mortensen O, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen A, Taudorf S, Pedersen B (2007) Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 50:2562-2571
8. Catalán V, Gómez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, Rodríguez A, Gil M, Cienfuegos J, Frühbeck G (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464-1474
9. Manuel S, Rahman S, Wigdahl B, Khan Z, Jain P (2007) Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front Biosci 12:4315-4335
10. Banchereau J, Steinman R (1998) Dendritic cells and control of immunity. Nature 392:245-252
11. Soehnlein O, Weber C (2009) Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol 31:35-47
12. Ge J, Jia Q, Liang C, Luo Y, Huang D, Sun A, Wang K, Zou Y, Chen H (2005) Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol 25:2157-2163
13. Seifarth C, Hinkmann D, Hahn E-G, Lohmann T, Harsch I (2008) Reduced frequency of peripheral dendritic cells in type 2 diabetes. Exp Clin Endocrinol Diabetes 116:162-166
14. Corrales J, Almeida M, Burgo R, Hernandez P, Miralles J, Orfao A (2007) Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications. J Diabetes Complications 21:41-49
15. Summers K, Marleau A, Mahon J, McManus R, Hramiak I, Singh B (2006) Reduced IFN-α secretion by blood dendritic cells in human diabetes. Clin Immunol 121:81-89
16. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072
17. Ju X-S, Hacker C, Scherer B, Redecke V, Berger T, Schuler G, Wagner H, Lipford G, Zenke M (2004) Immunoglobulin-like transcripts ILT2, ILT3, and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 331:159-164
18. Kohrgruber N, Halanek N, Groger M, Winter D, Rappersberger K, Schmitt-Egenolf M, Stingl G, Maurer D (1999) Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J Immunol 163:3250-3259
19. intermediate dendritic cells from bone marrow precursors. J Immunol 172:1426-1436
20. Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone B, Socci C, Di Carlo V (1999) Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473-6481
21. Ma D, Clark E (2009) The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 21:265-272
22. Serbina N, Salazar-Mather T, Biron C, Kuziel W, Pamer E (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70
23. Matzinger P (1994) Tolerance, danger, and the extended family. Ann Rev Immunol 12:991-1045
24. Varo N, Libby P, Nuzzo R, Italiano J, Doria A, Schönbeck U (2005) Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products. Diab Vasc Dis Res 2:81-87
25. Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual A, Bernal M, Fernádez-Cruz A, Veves A, Jarolim P, Varo J, Goldfine A, Horton E, Schönbeck U (2003) Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients. A novel target of thiazolidinediones. Circulation 107:2664-2669
26. Blüml S, Kirchberger S, Bochkov V, Krönke G, Stuhlmeier K, Majdic O, Zlabinger G, Knapp W, Binder B, Stöckl J, Leitinger N (2005) Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 175:501-508
27. Trevejo J, Marino M, Philpott N, Josien R, Richards E, Elkon K, Falck-Pedersen E (2001) TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 98:12162-12167
28. Blanco P, Palucka A, Pascual V, Banchereau J (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19:41-52
29. Palucka A, Blanck J-P, Bennett L, Pascual V, Banchereau J (2005) Cross-regulation of TNF and IFN-α in autoimmune diseases. Proc Natl Acad Sci USA 102:3372-3377
30. Buse J, Bigger J, Byington R, Cooper L, Cushman W, Friedewald W, Genuth S, Gerstein H, Ginsberg H, Goff D, Grimm R, Margolis K, Probstfield J, Simons-Morton D, Sullivan M (2007) Action to control cardiovascular risk in diabetes (ACCORD) trial: design and methods. Am J Cardiol 99:S21-S33
31. Ida J, Shrestha N, Desai S, Pahwa S, Hanekom W, Haslett P (2006) A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J Immunol Methods 310:86-99
32. Sato K, Fujita S (2007) Dendritic cells: nature and classification. Allergol Int 56:183-191
33. Della Bella S, Giannelli S, Taddeo A, Presicce P, Villa M (2008) Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods 339:153-164
34. Wang J-CE, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, Quataert S (2009) An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods 341:106-116
35. American Diabetes Association (2007) Standards of medical care in diabetes. Diabetes Care S4-S41
36. The action to control cardiovascular risk in diabetes study group, Gerstein H, Miller M, Byington R, Goff D, Bigger J, Buse J, Cushman W, Genuth S, Ismail-Beigi F, Grimm R, Probstfield J, Simons-Morton D, Friedewald W (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
37. Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743-1751
38. Vlad G, Chang C-C, Colovai A, Berloco P, Cortesini R, Suciu-Foca N (2009) Immunoglobulin-like transcript 3: a crucial regulator of dendritic cell function. Hum Immunol 70:340-344
39. Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109:3625-3632
40. Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S, Vecchi A, Franssen J-D, Communi D, Massardi L, Sironi M, Mantovani A, Parmentier M, Facchetti F, Sozzani S (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 201:509-515
41. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer M, Schäffler A, Aslanidis C, Schölmerich J, Buechler C (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol 72:342-348
42. Weis M, Schlichting C, Engleman E, Cooke J (2002) Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22:1817-1823
43. Kadowaki N, Ho S, Antonenko S, Malefyt R, Kastelein R, Bazan F, Liu Y (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194:863-869
44. Kadowaki N, Antonenko S, Lau JY-N, Liu Y-J (2000) Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219-226
45. Jing Y, Shaheen E, Drake R, Chen N, Gravenstein S, Deng Y (2009) Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 70:777-784
46. Kalofoutis C, Piperi C, Zisaki A, Singh J, Harris F, Phoenix D, Alaveras A, Kalofoutis A (2006) Differences in expression of cardiovascular risk factors among type 2 diabetes mellitus patients of different age. Ann N Y Acad Sci 1084:166-177
47. Paolisso G, Rizzo M, Mazziotti G, Tagliamonte M, Gambardella A, Rotondi M, Carella C, Giugliano D, Varricchio M, D'Onofrio F (1998) Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab 275:E294-E299
48. Katsuki A, Sumida Y, Murata K, Furuta M, Araki-Sasaki R, Tsuchihashi K, Hori Y, Yano Y, Gabazza E, Adachi Y (2000) Troglitazone reduces plasma levels of tumor necrosis factor-α; in obese patients with type 2 diabetes. Diabetes Obes Metab 2:189-191
49. Buckland M, Jago D, Fazekesova H, Scott K, Tan P, George A, Lechler R, Lombardi G (2006) Aspirin-treated human DCs up-regulate ILT-3 and induce hypo responsiveness and regulatory activity in responder T cells. Am J Transplant 6:2046-2059
50. Ho L-J, Chang D-M, Shiau H-Y, Chen C-H, Hsieh T-Y, Hsu Y-L, Wong C-S, Lai J-H (2001) Aspirin differentially regulates endotoxin-induced IL-12 and TNFα production in human dendritic cells. Scand J Rheumatol 30:346-352
51. Gosset P, Charbonnier A-S, Delerive P, Fontaine J, Staels B, Pestel J, Tonnel A-B, Trottein F (2001) Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol 31:2857-2865
52. Soumelis V, Liu Y-J (2006) From plasmacytoid to dendritic cell: Morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 36:2286-2292